(Q52996866)

10 May 2018

title

Adverse Events after Protamine Administration in Patients Undergoing Cardiopulmonary Bypass: Risks and Predictors of Under-Reporting (English)

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

7 December 2024

main subject

cardiopulmonary bypass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

7 December 2024

4

L. R. Goldberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

7 December 2024

author name string

S. E. Kimmel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

7 December 2024

M. A. Sekeres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

7 December 2024

J. A. Berlin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

7 December 2024

B. L. Strom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

7 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9467629

7 December 2024

publication date

1 January 1998

1 reference

10 May 2018

January 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9467629

full work available at URL

7 December 2024

https://doi.org/10.1016/s0895-4356(97)00241-2

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9467629

https://api.elsevier.com/content/article/PII:S0895435697002412?httpAccept=text/xml

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

https://api.elsevier.com/content/article/PII:S0895435697002412?httpAccept=text/plain

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Journal of Clinical Epidemiology

7 December 2024

published in

1 reference

10 May 2018

volume

51

1 reference

10 May 2018

issue

1

1 reference

10 May 2018

page(s)

1-10

1 reference

10 May 2018

Drug-induced Blood Dyscrasias in Sweden

cites work

2

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions

7 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital

7 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery.

7 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Systemic and pulmonary circulatory effects of protamine following cardiopulmonary bypass in man.

7 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Prophylactic administration of histamine1 and histamine2 receptor blockers in the prevention of protamine-related haemodynamic effects

7 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine

7 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state.

7 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non-diabetic patients

7 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

A systematic integrated approach to improvement of drug prescribing in an acute care hospital: a potential model for applied hospital pharmacoepidemiology

7 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Pretreatment with H2 blocker famotidine to ameliorate protamine-induced hypotension in open-heart surgery

7 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery

7 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep

7 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes

7 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

Why do doctors not report adverse drug reactions?

7 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

A nationwide investigation of a possible protamine drug-product defect

7 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/S0895-4356(97)00241-2

7 December 2024

Identifiers

1 reference

10 May 2018

1 reference

10 May 2018